{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:12:41Z","timestamp":1775722361501,"version":"3.50.1"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T00:00:00Z","timestamp":1413417600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003231","type":"journal-article","created":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T17:46:44Z","timestamp":1413827204000},"page":"e3231","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Hepatotoxicity in Mice of a Novel Anti-parasite Drug Candidate Hydroxymethylnitrofurazone: A Comparison with Benznidazole"],"prefix":"10.1371","volume":"8","author":[{"given":"Carolina","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilay","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga Sanchez","family":"Negrette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Antonio","family":"Parada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Basombrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha Jain","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,10,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.pt.2006.09.011","article-title":"The future of Chagas disease control","volume":"22","author":"CJ Schofield","year":"2006","journal-title":"Trends Parasitol"},{"key":"ref2","unstructured":"World Health Organization (2010) Chagas disease: control and elimination. UNDP\/World Bank\/WHO. http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA63\/A63_17-en.pdf<\/ext-link>, accessed 08\/28\/21014"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1462-5822.2012.01764.x","article-title":"Mechanisms of Trypanosoma cruzi<\/italic> persistence in Chagas disease","volume":"14","author":"F Nagajyothi","year":"2012","journal-title":"Cell Microbiol"},{"key":"ref4","first-page":"323","article-title":"Chagas disease: Present status of pathogenic mechanisms and chemotherapy","volume":"43","author":"JD Maya","year":"2010","journal-title":"Biol Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches","volume":"115","author":"JA Urbina","year":"2010","journal-title":"Acta Trop"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1590\/S0037-86822012000300002","article-title":"Chagas disease. What is known and what should be improved: a systemic review","volume":"45","author":"JR Coura","year":"2012","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref7","first-page":"721","article-title":"Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi<\/italic> strains of different types","volume":"63","author":"SG Andrade","year":"1985","journal-title":"Bull World Health Organ"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","article-title":"Susceptibility and natural resistance of Trypanosoma cruzi<\/italic> strains to drugs used clinically in Chagas disease","volume":"81","author":"LS Filardi","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1590\/S0037-86822003000200002","article-title":"Trypanosoma cruzi<\/italic>: susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain","volume":"36","author":"EL Camandaroba","year":"2003","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1073\/pnas.85.15.5374","article-title":"\u201cSubversive\u201d substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease","volume":"85","author":"GB Henderson","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1128\/AAC.01451-09","article-title":"Hydroxymethylnitrofurazone is active in a murine model of Chagas' disease","volume":"54","author":"C Davies","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/mutage\/gei026","article-title":"Comparative genotoxic evaluation of 2-furylethylenes and 5-nitrofurans by using the comet assay in TK6 cells","volume":"20","author":"JI Gonzalez Borroto","year":"2005","journal-title":"Mutagenesis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/019262330002800503","article-title":"A mechanistic study of ovarian carcinogenesis induced by nitrofurazone using rasH2 mice","volume":"28","author":"K Takegawa","year":"2000","journal-title":"Toxicol Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0278-6915(89)90008-2","article-title":"Toxicity and carcinogenicity of nitrofurazone in F344\/N rats and B6C3F1 mice","volume":"27","author":"FW Kari","year":"1989","journal-title":"Food Chem Toxicol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1016\/j.bmc.2003.07.004","article-title":"Synthesis and in vitro evaluation of potential antichagasic hydroxymethylnitrofurazone (NFOH-121): a new nitrofurazone prodrug","volume":"11","author":"MC Chung","year":"2003","journal-title":"Bioorg Med Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/S0100-879X2007000100005","article-title":"Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi<\/italic> messenger RNAs","volume":"40","author":"CF Barbosa","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"ref17","first-page":"19","article-title":"Toxic effects of nifurtimox and benznidazole, two drugs used against American trypanosomiasis (Chagas' disease)","volume":"1","author":"JA Castro","year":"1988","journal-title":"Biomed Environ Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/14756360902941058","article-title":"Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi<\/italic>","volume":"25","author":"GH Trossini","year":"2010","journal-title":"Spanish J Enzyme Inhib Med Chem"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Ara\u00fajo-Jorge TC, Castro LS (2000) Doen\u00e7a de Chagas: manual de experimenta\u00e7\u00e3o animal. Instituto Oswaldo Cruz, Rio de Janeiro, Brazil: FIOCRUZ. pp. 133\u2013173.","DOI":"10.7476\/9788575413937"},{"key":"ref20","first-page":"e2364","article-title":"Innate immune responses and antioxidant\/oxidant imbalance are major determinants of human Chagas disease","volume":"7","author":"M Dhiman","year":"2013","journal-title":"Plos NTD"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e000302","DOI":"10.1161\/JAHA.113.000302","article-title":"MnSODtg<\/sup> mice control myocardial inflammatory and oxidative stress and remodeling responses elicited in chronic Chagas disease","volume":"2","author":"M Dhiman","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1042\/BJ20040356","article-title":"Gene expression analysis in mitochondria from chagasic mice: Alterations in specific metabolic pathways","volume":"381","author":"NJ Garg","year":"2004","journal-title":"Biochemical J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/path.2975","article-title":"NADPH oxidase inhibition ameliorates Trypanosoma cruzi<\/italic>-induced myocarditis during Chagas disease","volume":"225","author":"M Dhiman","year":"2011","journal-title":"J Pathol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1065-6995(03)00173-2","article-title":"Production of hydrogen peroxide by peripheral blood monocytes and specific macrophages during experimental infection with Trypanosoma cruzi<\/italic> in vivo","volume":"27","author":"RC Melo","year":"2003","journal-title":"Cell Biol Int"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1074\/jbc.M110.167247","article-title":"Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi<\/italic>: consequences for oxidative killing and role of microbial peroxiredoxins in infectivity","volume":"286","author":"MN Alvarez","year":"2011","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.7883\/yoken.JJID.2004.S31","article-title":"Reactions of superoxide with myeloperoxidase and its products","volume":"57","author":"CC Winterbourn","year":"2004","journal-title":"Jpn J Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/CVI.00019-09","article-title":"Increased myeloperoxidase activity and protein nitration are indicators of inflammation in chagasic patients","volume":"16","author":"M Dhiman","year":"2009","journal-title":"Clinical and Vaccine Immunology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0022-2275(20)32182-9","article-title":"Lipid hydroperoxide generation, turnover, and effector action in biological systems","volume":"39","author":"AW Girotti","year":"1998","journal-title":"Spanish J Lipid Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vetimm.2009.01.004","article-title":"Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-gamma, TNF-alpha, and low IL-10 production during the acute infection phase","volume":"130","author":"PM Guedes","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"ref30","first-page":"469","article-title":"Nifurtimox-induced alterations in the cell-mediated immune response to PPD tin guinea-pigs","volume":"30","author":"R Lelchuk","year":"1977","journal-title":"Clin Exp Immunol"},{"key":"ref31","first-page":"139","article-title":"[Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation]","volume":"30","author":"JR Coura","year":"1997","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-4274(02)00238-2","article-title":"Nifurtimox biotransformation to reactive metabolites or nitrite in liver subcellular fractions and model systems","volume":"136","author":"M Montalto de Mecca","year":"2002","journal-title":"Toxicol Lett"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1191\/0960327106het653oa","article-title":"Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)","volume":"25","author":"JA Castro","year":"2006","journal-title":"Hum Exp Toxicol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/0960327107084540","article-title":"Early nifurtimox-induced biochemical and ultrastructural alterations in rat heart","volume":"26","author":"LC Bartel","year":"2007","journal-title":"Hum Exp Toxicol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/AAC.01401-12","article-title":"Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease","volume":"57","author":"MJ Pinazo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1128\/AAC.00537-10","article-title":"Tolerance of benznidazole in treatment of Chagas' disease in adults","volume":"54","author":"MJ Pinazo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1542\/peds.2010-1172","article-title":"Adverse events after the use of benznidazole in infants and children with Chagas disease","volume":"127","author":"J Altcheh","year":"2011","journal-title":"Pediatrics"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1590\/S0037-86822003000400002","article-title":"Treatment with benznidazole in association with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi<\/italic>: investigation into the possible development of neoplasias","volume":"36","author":"SG Andrade","year":"2003","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1128\/AAC.02522-12","article-title":"Pharmacokinetics of hydroxymethylnitrofurazone, a promising new prodrug for chagas' disease treatment","volume":"57","author":"EO Serafim","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/18723128112069990013","article-title":"Pharmacokinetics of hydroxymethylnitrofurazone and its parent drug nitrofurazone in rabbits","volume":"7","author":"MA Nogueira Filho","year":"2013","journal-title":"Drug Metab Lett"},{"key":"ref41","first-page":"781","article-title":"Damage to mammalian cell DNA by nitrofurans","volume":"35","author":"PL Olive","year":"1975","journal-title":"Cancer Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2004.05.016","article-title":"Mechanism of carcinogenesis induced by a veterinary antimicrobial drug, nitrofurazone, via oxidative DNA damage and cell proliferation","volume":"215","author":"Y Hiraku","year":"2004","journal-title":"Cancer Lett"},{"key":"ref43","first-page":"718","article-title":"[Nifurtimox and benznidazole inhibit DNA and protein synthesis in rat hepatocytes]","volume":"48","author":"SG Goijman","year":"1988","journal-title":"Medicina (B Aires)"},{"key":"ref44","article-title":"Alterations of mitochondria in liver but not in heart homogenates after treatment of rats with benznidazole","author":"D Rendon","year":"2014","journal-title":"Hum Exp Toxicol"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T07:18:23Z","timestamp":1746429503000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003231"}},"subtitle":[],"editor":[{"given":"Michael P.","family":"Pollastri","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,16]]},"references-count":44,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003231","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,16]]}}}